Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0015695 (
fatty liver
)
13,941
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Liver protocallagen proline hydroxylase activity (
PPH
activity) was determined in patients with various liver diseases, CCl4-induced liver fibrosis rats and cholin deficiency (tcd)
fatty liver
rats. The following results were obtained: Liver
PPH
activity in patients with chronic hepatitis was higher than that in patients with acute hepatitis, while the activity in patients with liver cirrhosis was much higher than that in patients with chronic hepatitis. The activity was higher in patients with chronic active hepatitis than in those with chronic inactive hepatitis. Patients with active and progressive liver cirrhosis were found to have an especially high
PPH
activity, in whom the activity reflected well the degree of liver fibrosis. Even though fibrosis in persistent hepatitis was almost negligible or slight, the degree of liver
PPH
activity in persistent hepatitis was similar to that in liver cirrhosis. Liver
PPH
activities in CCl4-induced liver fibrosis rats and CD
fatty liver
rats elevated proportionally to the lapse of time. Whilst liver
PPH
activity in rats of CD
fatty liver
without fibrosis in 23 to 31 weeks after the start of the experiment was slightly lower than that in rats of CD
fatty liver
with fibrosis. But liver
PPH
activity of the former was considerably higher than that of control rats.
...
PMID:Liver protocollagen proline hydroxylase in human liver diseases and experimental liver fibrosis. 19 57